RSK1 is an exploitable dependency in myeloid malignancies [CUT&Tag]
RSK1 is an exploitable dependency in myeloid malignancies Overall design: THP-1 cells were treated with DMSO or 5 µM PMD-026 for 24h. CUT&Tag was performed using H3K27ac antibodies or IgG control.